; Pharmaceutical Business Confidence Report Q1 2014
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Pharmaceutical Business Confidence Report Q1 2014

VIEWS: 5 PAGES: 59

  • pg 1
									 Pharmaceutical Business Confidence
 Report Q1 2014




Reference code: KG4020PR
Published: January 2014



                           1
AGENDA




Section 1: Economic overview

• Methodology and sample size

• Confidence indexes

• State of the economy

• Growth prospects and customer confidence

• Supplier prices and levels of expenditure

• Organizational outlook and strategy

• Appendix




                                              2
METHODOLOGY AND SAMPLE SIZE


Online Survey

This report is the result of an extensive survey drawn from Kable’s exclusive panel of industry executives. These
respondents are drawn from the Kable Industry Insight Panel, an exclusive industry panel covering business professionals
worldwide. These business communities are made up of highly engaged, qualified professionals who rely on our flagship
media brands in their respective markets, enabling Kable to access knowledgeable and informed industry opinion.

The research source in this report is based on the surveyed
opinions and expectations of 161 global pharmaceutical industry
executives, surveyed in January 2014. In addition, this report
presents comparative analysis of survey results with Q4 2013
(wherever applicable).

Comprehensive desk research was also conducted across
pharmaceutical industry sources, with a focus on examining the
current state of the economy, the impact of supplier prices,
industry growth prospects, customer confidence, and the market
trends that are currently affecting the industry. It also covers
discussion about examples of the latest products,
								
To top